» Articles » PMID: 14630716

An Octamer Motif is Required for Activation of the Inducible Nitric Oxide Synthase Promoter in Pancreatic Beta-cells

Overview
Journal Endocrinology
Specialty Endocrinology
Date 2003 Nov 25
PMID 14630716
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Nitric oxide, generated by the inducible form of nitric oxide synthase (iNOS), is a potential mediator of cytokine-induced beta-cell dysfunction in type 1 diabetes mellitus. We have previously shown that cytokine-induced iNOS expression is cycloheximide (CHX) sensitive and requires nuclear factor-kappa B (NF-kappa B) activation. In the present study, we show that an octamer motif located 20 bp downstream of the proximal NF-kappa B binding site in the rat iNOS promoter is critical for IL-1 beta and interferon-gamma induction of promoter activity in rat primary beta-cells and insulin-producing RINm5F cells. In gel shift assays, the octamer motif bound constitutively the transcription factor Oct1. Neither Oct1 nor NF-kappa B binding activities were blocked by CHX, suggesting that other factor(s) synthesized in response to IL-1 beta contribute to iNOS promoter induction. The high mobility group (HMG)-I(Y) protein also bound the proximal iNOS promoter region. HMG-I(Y) binding was decreased in cells treated with CHX and HMG-I(Y) silencing by RNA interference reduced IL-1 beta-induced iNOS promoter activity. These results suggest that Oct1, NF-kappa B, and HMG-I(Y) cooperate for transactivation of the iNOS promoter in pancreatic beta-cells.

Citing Articles

Extracellular HMGB1 exacerbates autoimmune progression and recurrence of type 1 diabetes by impairing regulatory T cell stability.

Zhang J, Chen L, Wang F, Zou Y, Li J, Luo J Diabetologia. 2020; 63(5):987-1001.

PMID: 32072192 PMC: 7145789. DOI: 10.1007/s00125-020-05105-8.


Frontline Science: Targeted expression of a dominant-negative high mobility group A1 transgene improves outcome in sepsis.

Baron R, Kwon M, Castano A, Ghanta S, Riascos-Bernal D, Lopez-Guzman S J Leukoc Biol. 2018; 104(4):677-689.

PMID: 29975792 PMC: 6431081. DOI: 10.1002/JLB.4HI0817-333RR.


The High Mobility Group A1 (HMGA1) Transcriptome in Cancer and Development.

Sumter T, Xian L, Huso T, Koo M, Chang Y, Almasri T Curr Mol Med. 2016; 16(4):353-93.

PMID: 26980699 PMC: 5408585. DOI: 10.2174/1566524016666160316152147.


Transcriptional profiling reveals functional links between RasGrf1 and Pttg1 in pancreatic beta cells.

Manyes L, Arribas M, Gomez C, Calzada N, Fernandez-Medarde A, Santos E BMC Genomics. 2014; 15:1019.

PMID: 25421944 PMC: 4301450. DOI: 10.1186/1471-2164-15-1019.


Transcriptional regulation of the HMGA1 gene by octamer-binding proteins Oct-1 and Oct-2.

Chiefari E, Arcidiacono B, Possidente K, Iiritano S, Ventura V, Pandolfo R PLoS One. 2013; 8(12):e83969.

PMID: 24367622 PMC: 3867479. DOI: 10.1371/journal.pone.0083969.